Vivos Inc.

09/18/2025 | Press release | Distributed by Public on 09/18/2025 14:01

Material Event (Form 8-K)

Item 8.01 Other Events.

On September 17, 2025, the Board of Directors of Vivos Inc. (the "Company") approved the creation of Vivos Scientific India LLP ("Vivos India"), a wholly owned separate legal entity in India. Vivos India expands the Company's strategic initiatives, with the objective of establishing a manufacturing center, expanding human therapies and pursuing commercialization of therapies in India. In addition, we will generate additional human trial data to support our process with the Food and Drug Administration ("FDA").

Vivos Inc. published this content on September 18, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on September 18, 2025 at 20:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]